The gastric antisecretory activity of 3-methoxy-5,7,3'4'-tetrahydroxyflavan (ME)--a specific histidine decarboxylase inhibitor in rats.
3-Methoxy-5,7,3'4'-tetrahydroxyflavan (ME), a specific histidine decarboxylase inhibitor, has been shown to significantly reduce the gastric acid secretion and gastric tissue histamine levels in 6 h pylorus ligated rats. It has been found to be as effective as cimetidine in reducing the gastric acid secretion. However, cimetidine does not affect the gastric tissues histamine levels in the normal or pylorus ligated rats. These observations clearly establish that the two drugs reduce the gastric acid secretion by different mechanisms and suggest that their combination may show a potentiated gastric anti-ulcer activity.
D000818:Animals; D000897:Anti-Ulcer Agents / Q000494:pharmacology*; D002262:Carboxy-Lyases / Q000037:antagonists & inhibitors*; D002392:Catechin / Q000031:analogs & derivatives; D002927:Cimetidine / Q000494:pharmacology; D005260:Female; D005419:Flavonoids / Q000494:pharmacology*; D005750:Gastric Juice / Q000378:metabolism*; D005753:Gastric Mucosa / Q000032:analysis; D006632:Histamine / Q000032:analysis; D006640:Histidine Decarboxylase / Q000037:antagonists & inhibitors*; D008297:Male; D051381:Rats
D000897:Anti-Ulcer Agents; D005419:Flavonoids; C029339:meciadanol; D002927:Cimetidine; D006632:Histamine; D002392:Catechin; D002262:Carboxy-Lyases; D006640:Histidine Decarboxylase